Neurobo Pharmaceuticals Inc NRBO
$2.36
+0.01
(0.43%)
Valuation
- Market cap
- 20,334,000
- Revenue TTM
- $0
- Net income TTM
- $-12,470,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 13,000
- Avg volume
- 45,138
- Day's range
- $2.32 – $2.44
- Shares out
- 8,616,000
- Stochastic %K
- 50%
- Beta
- -0.26
- Analysts
- Strong Buy
- Price target
- $26.67
Latest news
No headlines yet.
